During the past decade, Desert Medical Advances conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Desert Medical Advances" are "Rheumatoid Arthritis" (2 trials), "Arthritis" (1 trials), "Autoimmune Diseases" (1 trials), "Connective Tissue Diseases" (1 trials) and "Immune System Diseases" (1 trials). Many other conditions were trialed in "Desert Medical Advances" in a lesser frequency.

Most popular intervention types in "Desert Medical Advances" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "LY3361237" (1 trials), "Peresolimab" (1 trials) and "efalizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Desert Medical Advances" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Desert Medical Advances". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Desert Medical Advances, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Desert Medical Advances, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".